AI Verdict
NEUP has stronger fundamentals based on our AI analysis.
NFBK vs NEUP Fundamental Comparison
| Metric | NFBK | NEUP |
|---|---|---|
| Revenue | $6.9M | $15.6M |
| Net Income | $796,000.0 | $-8.0M |
| Net Margin | 11.6% | -51.4% |
| ROE | 0.1% | -27.1% |
| ROA | 0.0% | -22.0% |
| Current Ratio | N/A | 9.04x |
| Debt/Equity | 0.97x | 0.00x |
| EPS | $0.02 | $-2.66 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NFBK vs NEUP: Frequently Asked Questions
Is NFBK or NEUP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEUP has stronger fundamentals. NFBK is rated STRONG SELL (85% confidence) while NEUP is rated SELL (68% confidence). This is not investment advice.
How does NFBK compare to NEUP fundamentally?
Northfield Bancorp, Inc. has ROE of 0.1% vs Neuphoria Therapeutics Inc.'s -27.1%. Net margins are 11.6% vs -51.4% respectively.
Which stock pays higher dividends, NFBK or NEUP?
NFBK has a dividend yield of N/A or no dividend while NEUP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NFBK or NEUP for long term?
For long-term investing, consider that NFBK has STRONG SELL rating with 85% confidence, while NEUP has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NFBK vs NEUP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NFBK vs NEUP, the AI consensus favors NEUP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.